论文部分内容阅读
目的了解农村地区居民代谢综合征(MS)的患病特征和影响代谢综合征的危险因素及其与心脑血管疾病的关系,为制定当地MS控制策略和措施提供初步依据。方法采用整群多级随机抽样方法,对辽宁省彰武县5个乡9个村中年龄大于20岁的成年居民进行调查,以现场询问和测量的方式填写调查表,并采集被调查者的血样进行血糖、血脂等生化指标的检测。结果该地区农村居民MS的患病率为11.0%,男性患病率12.8%,女性患病率9.8%。标化后MS的患病率为16.43%。呈现随年龄增长MS患病增多的趋势。年龄、性别、高血压遗传、每日用盐量进入MS的危险模型。MS患病在患过脑卒中的病例组和没患过脑卒中疾病的对照组有统计学差异(χ2=31.49,P<0.01)。MS患病在患过冠心病的病例组和没患过冠心病的对照组有统计学差异(χ2=22.42,P<0.01)。伴随着代谢异常成分数的增加患脑梗死、脑出血、心脑血管疾病数也增加。结论农村地区MS主要代谢异常成分为高体质指数、高血压、高甘油三酯,MS及代谢异常成分可能是心脑血管疾病的危险因素。
Objective To understand the prevalence of metabolic syndrome (MS) and the risk factors affecting metabolic syndrome (MS) in rural areas and its relationship with cardiovascular and cerebrovascular diseases, and to provide preliminary evidence for the development of local MS control strategies and measures. Methods The method of cluster multistage random sampling was used to investigate adult residents older than 20 years old in 9 villages of 5 townships in Zhangwu County, Liaoning Province. Fill in the questionnaires with on-site inquiry and measurement, and collect the respondents’ Blood samples for blood glucose, blood lipid and other biochemical detection. Results The prevalence of MS among rural residents in this area was 11.0%, the prevalence rate was 12.8% in males and 9.8% in females. The standardized prevalence of MS was 16.43%. Showing the increasing prevalence of MS with age trends. Age, gender, high blood pressure genetic, daily salt intake into the MS risk model. There was a significant difference in the prevalence of MS between the stroke group and the control group without the disease (χ2 = 31.49, P <0.01). MS prevalence in patients with coronary heart disease and coronary heart disease control group had no significant difference (χ2 = 22.42, P <0.01). Accompanied by an increase in the number of metabolic abnormalities suffering from cerebral infarction, cerebral hemorrhage, cardiovascular and cerebrovascular diseases also increased. Conclusion The major metabolic abnormalities of MS in rural areas are high body mass index. Hypertension, hypertriglyceridemia, MS and metabolic abnormalities may be the risk factors of cardiovascular and cerebrovascular diseases.